These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28900725)

  • 21. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
    Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
    Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.
    Murakami T; Imai Y; Okada M; Hyodo T; Lee WJ; Kim MJ; Kim T; Choi BI
    Oncology; 2011; 81 Suppl 1():86-99. PubMed ID: 22212941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of contrast-enhanced ultrasonography with grey-scale ultrasonography and contrast-enhanced computed tomography in diagnosing focal fatty liver infiltrations and focal fatty sparing.
    Janica J; Ustymowicz A; Lukasiewicz A; Panasiuk A; Niemcunowicz-Janica A; Turecka-Kulesza E; Lebkowska U
    Adv Med Sci; 2013; 58(2):408-18. PubMed ID: 24133114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma.
    Tarantino L; Ambrosino P; Di Minno MN
    World J Gastroenterol; 2015 Aug; 21(32):9457-60. PubMed ID: 26327753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Gray-Scale Ultrasonography Immediate Post-Contrast on Characterization of Focal Liver Lesions.
    Yang W; Chen MH; Wu W; Dai Y; Fan ZH
    Biomed Res Int; 2015; 2015():193178. PubMed ID: 26090387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathologic explanation for hypoechoic halo seen on sonograms of malignant liver tumors: an in vitro correlative study.
    Wernecke K; Henke L; Vassallo P; von Bassewitz DB; Diederich S; Peters PE; Edel G
    AJR Am J Roentgenol; 1992 Nov; 159(5):1011-6. PubMed ID: 1329455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
    Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D
    Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
    Quaia E; De Paoli L; Angileri R; Pizzolato R; Cabibbo B; Cova MA
    Abdom Imaging; 2013 Dec; 38(6):1245-53. PubMed ID: 24026173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient hepatic echogenicity difference on contrast-enhanced ultrasonography: sonographic sign and pitfall.
    Catalano O; Sandomenico F; Nunziata A; Raso MM; Vallone P; Siani A
    J Ultrasound Med; 2007 Mar; 26(3):337-45. PubMed ID: 17324983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focally spared area of fatty liver that receives blood passing through the sinusoids of a hypervascular hepatocellular carcinoma.
    Murakami T; Kim T; Sugiura T; Hori M; Takamura M; Wakasa K; Nakamura H
    J Comput Assist Tomogr; 1999; 23(2):320-2. PubMed ID: 10096347
    [No Abstract]   [Full Text] [Related]  

  • 32. Aberrant gastric venous drainage in cirrhotic livers: imaging findings in focal areas of liver parenchyma.
    Matsui O; Kadoya M; Yoshikawa J; Gabata T; Takahashi S; Ueda K; Kawamori Y; Takashima T; Nakanuma Y
    Radiology; 1995 Nov; 197(2):345-9. PubMed ID: 7480675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Well-differentiated HCC manifesting hyperattenuation on CT during arterial portography.
    Kim SR; Kim KI; Maekawa Y; Imoto S; Ninomiya T; Mita K; Ando K; Fukuda K; Fuki S; Kudo M; Matsuoka T; Sasase N; Taniguchi M; Hayashi Y
    Hepatogastroenterology; 2005; 52(65):1559-62. PubMed ID: 16201119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focal liver lesions: sinusoidal phase of CEUS.
    D'Onofrio M; Martone E; Faccioli N; Zamboni G; Malagò R; Mucelli RP
    Abdom Imaging; 2006; 31(5):529-36. PubMed ID: 16802201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of tumor response to intra-arterial chemoembolization of hepatocellular carcinoma: Comparison of contrast-enhanced ultrasound with multiphase computed tomography.
    Paul SB; Dhamija E; Gamanagatti SR; Sreenivas V; Yadav DP; Jain S; Shalimar ; Acharya SK
    Diagn Interv Imaging; 2017 Mar; 98(3):253-260. PubMed ID: 27692674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
    Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging of intrahepatic progression of hepatocellular carcinoma post transarterial chemoembolization. A long-term, prospective evaluation of contrast-enhanced ultrasonography (CEUS).
    Moschouris H; Kalokairinou-Motogna M; Vrakas S; Papadatou A; Karagiannis E; Kiltenis M; Kladis-Kalentzis K; Marmaridou K; Papadogeorgopoulos N; Malagari K
    Med Ultrason; 2017 Apr; 19(2):134-142. PubMed ID: 28440346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma.
    Martie A; Sporea I; Popescu A; Sirli R; Dănilă M; Serban C; Ardelean M; Bota S; Sendroiu M; Chisevescu D
    Med Ultrason; 2011 Jun; 13(2):108-13. PubMed ID: 21655536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma.
    Park KH; Kwon SH; Lee YS; Jeong SW; Jang JY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Kim YJ
    Clin Mol Hepatol; 2015 Jun; 21(2):158-64. PubMed ID: 26157753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early diagnosis of small hepatocellular carcinoma by new contrast-enhanced ultrasound technique].
    Chen MH; Dai Y; Yan K; Fan ZH; Wu W; Wang YB; Yin SS; Yang W; Li JY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):458-62. PubMed ID: 16224512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.